Search

everythinglearnresearchcommunity

for

Search:↓

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Stress hormone CRF causes hair loss and stops hair cell growth.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Noncrosslinked hyaluronic acid helps human hair cells grow and could be a potential hair loss treatment.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

Stress can worsen some skin diseases like psoriasis and eczema.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Age, gender, and hair loss affect scalp characteristics differently in young Caucasian adults.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Fat-derived stem cells and their secretions show promise for treating skin aging and hair loss.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Different types of hair loss require specific treatments, and new treatments are being developed.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

A combined approach of medical treatments, natural remedies, diet, and stress management is best for hair regrowth in Cambodia.

Justicia procumbens extract may help prevent hair loss and improve hair thickness and shine in a type of hair loss condition.

Ageing and increased senescent cells significantly contribute to common hair loss.

NMN could potentially treat hair loss by reducing oxidative stress and improving cell health.

Blocking autophagy increases survival of inner ear hair cells exposed to gentamicin.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.